Stay updated on Mirikizumab Efficacy in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Mirikizumab Efficacy in Ulcerative Colitis Clinical Trial page.

Latest updates to the Mirikizumab Efficacy in Ulcerative Colitis Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was applied, replacing v3.4.2. No study-related content or functionality appears to have changed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the history. Removed the government funding lapse notice and the Revision: v3.4.1 entry.SummaryDifference0.3%

- Check41 days agoChange DetectedA new system notice about a lapse in government funding has been added and directs users to cc.nih.gov and opm.gov for updates. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check48 days agoChange DetectedThe page now includes a 'Show glossary' option and uses color-coded highlights (green for additions, red for deletions) to explain changes. Revision notes were updated from v3.3.4 to v3.4.0 and the 'No FEAR Act Data' label was adjusted.SummaryDifference0.4%

- Check62 days agoChange DetectedRevision history updated with the addition of v3.3.4 and removal of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision: v3.3.3 has been added to the footer, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed.SummaryDifference0.1%

Stay in the know with updates to Mirikizumab Efficacy in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirikizumab Efficacy in Ulcerative Colitis Clinical Trial page.